Intermountain Health Care
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Intermountain Health Care sits in the top decile of US sponsors by registered trial count (#268 of 15,742 sponsors by registered trial count).
Intermountain Health Care: 85 sponsored US clinical trials, 11 recruiting.
Intermountain Health Care sponsors 85 registered US clinical trials on ClinicalTrials.gov, 11 of them currently recruiting, and 55 completed. 14 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pediatric Infectious Disease, with 2 trials.
Top-decile sponsor footprint
Intermountain Health Care ranks in the top decile of sponsors by registered trial count (#268 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
55 of 65 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
85 total, page 2 of 2
Systems Biology Approach to Cognitive Impairment After SepsiS
NCT03015584
Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)
NCT03226366
Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation
NCT02562404
Echo vs. EGDT in Severe Sepsis and Septic Shock
NCT02354742
Patient Ambulation in Post-Op Recovery
NCT02528669
Promoting Patient-Centered Care Through a Heart Failure Simulation Study
NCT01917188
Intermountain Risk Score and Trauma
NCT02011412
The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
NCT01887353
The Fasting II Study
NCT01792986
Outpatient Treatment of Low-risk Pulmonary Embolism
NCT02355548
Hypobaria and Traumatic Pneumothorax
NCT01670942
Test of Chamber Pressure to Divers and Chamber Attendants
NCT01430325
Methadone Monitoring for Insights Into Adverse Events
NCT01191242
Intermountain Healthcare's Enhanced Recovery Protocol for Colon Surgery With and Without Alvimopan Use
NCT01143259
Expression of Longevity Genes in Response to Extended Fasting
NCT01059760
The Value of Traction in the Treatment of Cervical Radiculopathy
NCT00979108
The Value of Traction in Treatment of Lumbar Radiculopathy
NCT00942227
Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy
NCT00769626
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
NCT00927862
Outcome Following Carbon Monoxide Poisoning in Children
NCT01059708
Functional and Anatomical Magnetic Resonance Imaging (MRI) of Chronic Brain Injury and Hyperbaric Oxygen (HBO2) Study Subjects
NCT01126515
The Purple Grape Juice Study
NCT00551746
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
NCT00465855
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
NCT00488033
Response to Medication Registry
NCT02593916
Exercise Treatment of Mild-Stage Probable Alzheimer's Disease
NCT00403507
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
NCT00343395
A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
NCT00334464
Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients
NCT00333697
Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial
NCT00343876
SAFEstart Feeding Intolerance Study Phase II
NCT00331201
ETCare: Safety and Preliminary Efficacy Trial
NCT01688440
The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
NCT00343499
Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury
NCT00830453
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
NCT00309712
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 4 |
| Phase 4 | 10 |
Where Intermountain Health Care enrollment is open (later-stage tilt)
11 recruiting of 85 indexed (13% open); 55 completed (65%).
Phase mix: 14 late (III/IV) vs 8 early (I/II) (later-stage heavy).
Top condition: Pediatric Infectious Disease (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Intermountain Health Care: open-pipeline peers nationwide
Peers matched on 85 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Intermountain Health Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 85 trials (± recruiting share)
- Ipsen · 85 trials · 19% recruiting
- Seagen · 84 trials · 0% recruiting
- Ferring Pharmaceuticals · 83 trials · 5% recruiting
- National Jewish Health · 83 trials · 8% recruiting
Sponsors near 13% open enrollment (± trial volume)
- University of Pittsburgh · 13% recruiting · 1,238 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this Intermountain Health Care page
85 registered trials is a research-attention snapshot, not an endorsement of Intermountain Health Care or any single study.
- 11 of Intermountain Health Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pediatric Infectious Disease is the condition Intermountain Health Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pediatric Infectious Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Intermountain Health Care pipeline card: 85 registered trials from official public datasets.Report a data error.